PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Avanos Medical, Inc. (AVNS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US05350V1061

CUSIP

05350V106

Sector

Healthcare

IPO Date

Oct 21, 2014

Highlights

Market Cap

$571.82M

EPS (TTM)

-$8.40

Total Revenue (TTM)

$521.70M

Gross Profit (TTM)

$286.50M

EBITDA (TTM)

-$359.20M

Year Range

$11.84 - $25.36

Target Price

$17.00

Short %

2.24%

Short Ratio

1.36

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
AVNS vs. SPY
Popular comparisons:
AVNS vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Avanos Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%150.00%200.00%NovemberDecember2025FebruaryMarchApril
-70.54%
165.71%
AVNS (Avanos Medical, Inc.)
Benchmark (^GSPC)

Returns By Period

Avanos Medical, Inc. had a return of -24.12% year-to-date (YTD) and -35.44% in the last 12 months. Over the past 10 years, Avanos Medical, Inc. had an annualized return of -13.15%, while the S&P 500 had an annualized return of 9.34%, indicating that Avanos Medical, Inc. did not perform as well as the benchmark.


AVNS

YTD

-24.12%

1M

-17.66%

6M

-47.18%

1Y

-35.44%

5Y*

-16.55%

10Y*

-13.15%

^GSPC (Benchmark)

YTD

-12.30%

1M

-8.99%

6M

-11.89%

1Y

3.84%

5Y*

13.06%

10Y*

9.34%

*Annualized

Monthly Returns

The table below presents the monthly returns of AVNS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20258.17%-12.60%-4.78%-15.70%-24.12%
2024-14.44%-3.23%7.22%-9.19%10.12%0.05%20.08%1.25%-0.78%-22.26%2.57%-16.91%-29.02%
202313.23%-8.39%5.95%-0.67%-17.06%4.33%-4.26%-14.02%-3.90%-9.20%17.37%4.08%-17.11%
2022-12.72%16.95%-5.34%-12.96%-1.61%-4.71%3.77%-13.18%-11.57%1.70%21.44%0.59%-21.95%
2021-1.26%1.50%-4.87%-1.21%-7.20%-9.30%4.32%-13.02%-5.45%1.09%-4.34%14.92%-24.43%
2020-18.28%17.68%-16.91%15.30%-6.41%1.14%4.36%5.64%2.53%6.41%19.92%8.23%36.14%
20191.70%3.36%-9.35%-1.71%-10.18%15.74%-6.63%-18.52%12.90%17.57%-21.30%-2.77%-24.76%
20185.70%1.17%-6.68%2.80%15.90%4.28%-3.58%30.62%-4.99%-17.37%-15.71%-6.12%-3.01%
20174.03%1.53%-2.48%3.70%-9.01%9.29%2.39%12.61%-0.57%-6.40%15.16%-4.86%24.88%
2016-25.77%2.90%12.58%-1.98%10.40%4.60%6.37%5.38%-4.91%-6.66%14.84%-0.46%10.69%
2015-1.98%3.30%6.86%-1.46%-14.56%-2.22%0.59%-22.83%-9.54%4.36%7.78%4.44%-26.52%
2014-7.39%3.27%15.97%10.90%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AVNS is 13, meaning it’s performing worse than 87% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AVNS is 1313
Overall Rank
The Sharpe Ratio Rank of AVNS is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of AVNS is 1010
Sortino Ratio Rank
The Omega Ratio Rank of AVNS is 1010
Omega Ratio Rank
The Calmar Ratio Rank of AVNS is 2727
Calmar Ratio Rank
The Martin Ratio Rank of AVNS is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Avanos Medical, Inc. (AVNS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for AVNS, currently valued at -0.95, compared to the broader market-2.00-1.000.001.002.003.00
AVNS: -0.95
^GSPC: 0.14
The chart of Sortino ratio for AVNS, currently valued at -1.27, compared to the broader market-6.00-4.00-2.000.002.004.00
AVNS: -1.27
^GSPC: 0.33
The chart of Omega ratio for AVNS, currently valued at 0.83, compared to the broader market0.501.001.502.00
AVNS: 0.83
^GSPC: 1.05
The chart of Calmar ratio for AVNS, currently valued at -0.42, compared to the broader market0.001.002.003.004.00
AVNS: -0.42
^GSPC: 0.14
The chart of Martin ratio for AVNS, currently valued at -1.47, compared to the broader market-5.000.005.0010.0015.0020.00
AVNS: -1.47
^GSPC: 0.62

The current Avanos Medical, Inc. Sharpe ratio is -0.95. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Avanos Medical, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
-0.95
0.14
AVNS (Avanos Medical, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Avanos Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-83.37%
-16.05%
AVNS (Avanos Medical, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Avanos Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Avanos Medical, Inc. was 83.44%, occurring on Apr 15, 2025. The portfolio has not yet recovered.

The current Avanos Medical, Inc. drawdown is 83.37%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-83.44%Sep 5, 20181662Apr 15, 2025
-53.8%Apr 9, 2015214Feb 11, 2016559May 2, 2018773
-12.63%Oct 22, 201414Nov 10, 201429Dec 22, 201443
-10.83%Jan 13, 201520Feb 10, 201527Mar 20, 201547
-9.56%Jun 19, 201829Jul 30, 20186Aug 7, 201835

Volatility

Volatility Chart

The current Avanos Medical, Inc. volatility is 13.32%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
13.32%
13.75%
AVNS (Avanos Medical, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Avanos Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Avanos Medical, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab